[go: up one dir, main page]

NO20050037L - Fremgangsmate som er i stand til HTS og testsystem for a bestemme interaksjonen mellom et C-reaktivt protein og komponenter som binder til et C-reaktivt protein - Google Patents

Fremgangsmate som er i stand til HTS og testsystem for a bestemme interaksjonen mellom et C-reaktivt protein og komponenter som binder til et C-reaktivt protein

Info

Publication number
NO20050037L
NO20050037L NO20050037A NO20050037A NO20050037L NO 20050037 L NO20050037 L NO 20050037L NO 20050037 A NO20050037 A NO 20050037A NO 20050037 A NO20050037 A NO 20050037A NO 20050037 L NO20050037 L NO 20050037L
Authority
NO
Norway
Prior art keywords
reactive protein
interaction
hts
test system
components
Prior art date
Application number
NO20050037A
Other languages
English (en)
Inventor
Aimo Kannt
Antje Pommereau
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Publication of NO20050037L publication Critical patent/NO20050037L/no

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/542—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with steric inhibition or signal modification, e.g. fluorescent quenching
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4737—C-reactive protein
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Det er beskrevet en fremgangsmåte og et testsystem som er i stand til HTS for bestemmelse av vekselvirkningen mellom C-reaktivt protein (CRP) henholdsvis Clq og til CRP henholdsvis Clq bindende komponenter, for konsentrasjonsbestemmelse av en CRP- henholdsvis Clq-holdig oppløsning samt for bestemmelse av stoffer som påvirker interaksjonen av CRP henholdsvis Clq og til disse bindende komponentene, spesielt vekselvirkningen mellom CRP og Clq.
NO20050037A 2002-06-12 2005-01-04 Fremgangsmate som er i stand til HTS og testsystem for a bestemme interaksjonen mellom et C-reaktivt protein og komponenter som binder til et C-reaktivt protein NO20050037L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10226011A DE10226011A1 (de) 2002-06-12 2002-06-12 HTS-fähiges Verfahren und Testsystem zur Ermittlung der Wechselwirkung zwischen c-reaktivem Protein und an C-reaktives Protein bindenden Komponenten
PCT/EP2003/006038 WO2003107000A2 (de) 2002-06-12 2003-06-10 Hts-fähiges verfahren und testsystem zur ermittlung der wechselwirkung zwischen c-reaktivem protein und an c-reaktives protein bindenden komponenten

Publications (1)

Publication Number Publication Date
NO20050037L true NO20050037L (no) 2005-01-04

Family

ID=29718976

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20050037A NO20050037L (no) 2002-06-12 2005-01-04 Fremgangsmate som er i stand til HTS og testsystem for a bestemme interaksjonen mellom et C-reaktivt protein og komponenter som binder til et C-reaktivt protein

Country Status (14)

Country Link
EP (1) EP1516187A2 (no)
JP (1) JP2005529348A (no)
CN (1) CN1745300A (no)
AR (1) AR040259A1 (no)
AU (1) AU2003250344A1 (no)
BR (1) BR0311709A (no)
CA (1) CA2489021A1 (no)
DE (1) DE10226011A1 (no)
MX (1) MXPA04012232A (no)
NO (1) NO20050037L (no)
RU (1) RU2005100042A (no)
TW (1) TW200411179A (no)
WO (1) WO2003107000A2 (no)
ZA (1) ZA200409199B (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102721813A (zh) * 2012-07-09 2012-10-10 沃克(天津)生物科技有限公司 前列腺特异抗原均相发光免疫分析检测试剂盒及其检测方法
CN103852465A (zh) * 2012-11-30 2014-06-11 通用电气公司 检测标记蛋白的方法和装置
AU2016341539A1 (en) * 2015-10-02 2018-04-26 Tgr Biosciences Pty Ltd. Analyte detection with multiple substrates
CN107976535B (zh) * 2017-11-03 2020-03-20 科美诊断技术股份有限公司 一种检测样本中目标IgM抗体的均相免疫检测试剂盒及其使用方法和应用
CN109752332A (zh) * 2017-11-07 2019-05-14 重庆中元汇吉生物技术有限公司 一种补体C1q检测试剂盒
CN108169497A (zh) * 2018-02-11 2018-06-15 北京科美生物技术有限公司 人泌乳素检测试剂盒及其制备方法与应用
CN108445239B (zh) * 2018-02-11 2021-11-02 科美诊断技术股份有限公司 检测β人绒毛膜促性腺激素的均相免疫检测试剂套装及其制备方法和应用
CN108490194A (zh) * 2018-02-11 2018-09-04 北京科美生物技术有限公司 检测卵泡刺激素的均相免疫检测试剂套装及其制备方法和应用
CN108445238A (zh) * 2018-02-11 2018-08-24 北京科美生物技术有限公司 检测促黄体生成素的均相免疫检测试剂套装及其制备方法和应用
CN108445216B (zh) * 2018-02-11 2021-10-15 科美诊断技术股份有限公司 一种人抗缪勒氏管激素测定试剂盒及其制备方法与应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0411017B1 (en) * 1988-04-04 1996-03-06 POTEMPA, Lawrence A. Binding of immune complexes by modified forms of c-reactive protein
US6140490A (en) * 1996-02-01 2000-10-31 Nexstar Pharmaceuticals, Inc. High affinity nucleic acid ligands of complement system proteins
US5283238A (en) * 1992-04-24 1994-02-01 Immtech International, Inc. Methods of treating cancer using modified C-reactive protein
JP3498960B2 (ja) * 1993-09-03 2004-02-23 デイド・ベーリング・マルブルク・ゲゼルシヤフト・ミツト・ベシユレンクテル・ハフツング 蛍光酸素チャンネリングイムノアッセイ
US6303325B1 (en) * 1998-05-29 2001-10-16 Dade Behring Inc. Method for detecting analytes

Also Published As

Publication number Publication date
JP2005529348A (ja) 2005-09-29
WO2003107000A3 (de) 2004-05-27
WO2003107000A2 (de) 2003-12-24
TW200411179A (en) 2004-07-01
AU2003250344A1 (en) 2003-12-31
BR0311709A (pt) 2005-03-15
AR040259A1 (es) 2005-03-23
RU2005100042A (ru) 2006-07-20
DE10226011A1 (de) 2004-01-08
CN1745300A (zh) 2006-03-08
ZA200409199B (en) 2005-05-18
MXPA04012232A (es) 2005-02-25
EP1516187A2 (de) 2005-03-23
CA2489021A1 (en) 2003-12-24

Similar Documents

Publication Publication Date Title
NO20050037L (no) Fremgangsmate som er i stand til HTS og testsystem for a bestemme interaksjonen mellom et C-reaktivt protein og komponenter som binder til et C-reaktivt protein
IS7611A (is) Örfylki og aðferð til þess að framkvæma blöndunarhvörf fyrir fjölda sýna á einu örfylki
DK1352238T3 (da) Fremgangsmåde til påvisning af D-vitaminmetabolitter
DE69308554D1 (de) Verbesserungen beim oder in zusammenhang mit analytnachweis
DK0559164T3 (da) Immunologisk fremgangsmåde til bestemmelse af HbA1c
DK1766400T3 (da) Fremgangsmåde til at udföre fuldblodsanalyser
WO2008002615A3 (en) Method and system for determining mobile emissions reduction credits
DE60330248D1 (de) Teststreifen zum analytnachweis und verwendungsverfahren
NO20031116L (no) Teststrips for deteksjon av tilstedev¶relsen av en redusert kofaktor i en pröve og fremgangsmåter for bruk av disse
WO2003093494A3 (en) Apparatus including ion transport detecting structures and methods of use
NO20076662L (no) Deteksjon av et malantigen uavhengig av tilstedevaerelse eller fravaer av et korresponderende terapeutisk antistoff
DK1173770T3 (da) Fremgangsmåde til vurdering af risikoen for mavesår
NO20070875L (no) Apparatkomponenter og fremgangsmater for a anvende disse for a detektere tilstedevaerelsen av et analytt
WO2006031883A3 (en) Analysis of mhc-peptide binding interactions
WO2002008766A1 (fr) Sonde permettant d'analyser une interaction protéine/protéine et méthode d'analyse utilisant cette sonde
NO964015L (no) Fremgangsmåte for påvisning av kalpain-aktivering og identifisering av kalpain-inhibitorer
FI973561A0 (fi) Menetelmä ja yhdisteitä analysoitavien aineiden määrittämiseksi remanenssimittausten avulla ja mainittujen yhdisteiden käyttö
ATE405837T1 (de) Festphase immunochromatographische testverfahren
AU2174002A (en) Method for analyzing proteins
DK1644513T3 (da) Assay til detektion af proteinbinding
ATE354090T1 (de) Verfahren zum bestimmen von crp mit hilfe von phosphorylcholin
DK1386160T3 (da) Fremgangsmåde til påvisning af blodcelle-antigener og antistoffer rettet mod disse
EP0672062A4 (en) A PETROLEUM IMMUNE TEST METHOD, ITS COMPONENTS AND KIT FOR THEIR USE.
GB0625756D0 (en) Analyte delection system
WO2003093817A3 (en) Method of identifying ligands for nuclear receptors

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application